IN

Healthcare · Pharmaceuticals

Ind-Swift Laboratories Ltd (INDSWFTLAB)

₹317.05

Mkt cap
₹3,142 Cr
P/E ratio
34.20
P/B
1.87
Div yield
0.00%
ROE
4.02%
ROCE
4.86%
EPS (TTM)
₹9.27
Book value
₹170
52W range
87–427
Sector
Healthcare

Price history

Previous close

Incorporated in 1995, Ind-Swift Laboratories Ltd is a pharmaceutical company focused on finished dosage formulations (FDF). Co. manufactures tablets, capsules, ointments, injectables, liquids and dry syrups across therapies including gynaecology, paediatrics, cardiology, diabetology and dermatology. Operations span domestic formulations and international markets through own brands, contract manufacturing and out-licensing. [1]

NSE INDSWFTLABBSE 532305
Health check
Cautious
ValuationFair
ProfitabilityWeak
GrowthLow
TechnicalsNeutral
52-week range
−25.68% from high
₹317
₹87+263.80% from low₹427
Current
₹317.05
Prev close
₹330.20
Day
−3.98%
Price performance
1D
−4.38%
1W
−12.61%
1M
−8.57%
3M
−5.33%
6M
+133.28%
1Y
+204.34%
YTD
+246.31%

Financials

Revenue, profit & margin
P/E ratio
34.2×
INDSWFTLAB is 1% above the sector median of 34.0×
INDSWFTLAB34.2×
Sector median34.0×
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales2902885293312129138153159151170191240
YoY Sales growth-7%-8%+74%-89%-96%-55%-74%+360%+1,226%+17%+23%+25%+52%
Expenses2242364374324135147149151147149158195
Operating Profit665291-10-12-7-9474213345
OPM %23%18%17%-29%-99%-5%-7%2.4%4.7%2.8%12%17%19%
Other Income77458111316220151222-377
Interest212130010-27121-211
Depreciation1314200067779888
Profit before tax392452711-7230101016123343
Tax %18%19%6%-3%31%-16%4%17%22%42%-26%25%21%
Net Profit321949410-52229810152534
EPS in Rs5.363.2983.550.160.07-0.9336.671.450.981.171.742.843.94
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move +14.07% · closed higher next day 1 of last 2
 Q1FY27Q2FY27
Broadcast10 Aug '26◦29 Oct '26
Earnings day+20.00%+8.14%
+1 day+26.45%−2.84%
+5 days+46.21%−5.86%
+15 days+55.18%−16.68%
+30 days+70.73%—
FilingXBRLXBRL

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
42.93%Promoter
Promoters42.93%
FIIs10.78%0.08
DIIs0.20%0.03
Public46.09%0.10
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,880.0036.664,51,0750.85%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,442.0088.893,03,7490.26%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,670.0081.821,77,6320.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,424.0097.751,30,9720.08%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,189.9026.201,18,6930.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,380.0041.171,15,2670.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,391.8036.211,12,4420.93%852−35.05%7,404−2.44%15.49%
Ind-Swift Labs.₹361.3034.243,1420.00%34+334.04%240+51.58%4.86%
Median: 160 Co.₹465.8333.992,0120.08%13+33.53%179+20.92%14.94%

Filings